Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $3.11 and traded as high as $3.15. Hypera shares last traded at $3.15, with a volume of 1,217 shares changing hands.
Hypera Trading Up 0.5 %
The company has a debt-to-equity ratio of 0.68, a current ratio of 1.81 and a quick ratio of 1.41. The firm has a 50-day moving average price of $3.11 and a two-hundred day moving average price of $4.28.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Further Reading
- Five stocks we like better than Hypera
- Stock Splits, Do They Really Impact Investors?
- MP Materials: Rare Earth Elements Powering the EV Boom
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
